0001921094-23-000739.txt : 20231005 0001921094-23-000739.hdr.sgml : 20231005 20231005163126 ACCESSION NUMBER: 0001921094-23-000739 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231005 DATE AS OF CHANGE: 20231005 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 231311739 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Cole Douglas G. CENTRAL INDEX KEY: 0001486373 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001486373 XXXXXXXX LIVE 0001714899 Denali Therapeutics Inc. 001-38311 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548 Cole Douglas G. Former Affiliate Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

11313 231751.00 137422131 10/05/2023 NASDAQ Common 06/01/2021 Restricted Stock Lapse Denali Therapeutics Inc. N 3253 06/01/2021 Equity Compensation Common 06/02/2022 Restricted Stock Lapse Denali Therapeutics Inc. N 2074 06/02/2022 Equity Compensation Common 06/02/2023 Restricted Stock Lapse Denali Therapeutics Inc. N 5986 06/02/2023 Equity Compensation Y 10/05/2023 Douglas G. Cole